Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today topline results from the pivotal Phase ...

Patients with COPD and chronic hypercapnic respiratory failure on noninvasive ventilation report similar quality of life ...

While numerous studies have assessed how much people with chronic obstructive pulmonary disease (COPD) walk, few have explored how they walk, especially in unsupervised, ...

Roche’s hopes of getting its chronic obstructive pulmonary disease (COPD) drug astegolimab to regulators this year have taken ...

The path to market for Roche’s astegolimab became more uncertain after the investigational antibody failed to significantly ...

Urine VOCs are linked to COPD risk and inflammation in NHANES data, suggesting potential for non-invasive screening with ...

As extreme heat settles over Illinois, the American Lung Association has tips to help residents safeguard their health. Extreme weather conditions, like the current heat wave, can be especially ...

Microsoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and improve our services and ads. If you agree, MSN and Microsoft Bing will ...

Topline data were announced from two phase 3 trials evaluating astegolimab in patients with moderate to very severe COPD.

Astegolimab from Roche's Genentech fails phase 3 COPD trial, reflecting challenges in monoclonal antibody treatment for the ...

Obama officials omitted Russian intel on Hillary Clinton’s alleged health problems while saying Russian President Vladimir Putin aimed to help President Donald Trump, according to newly declassified ...

Residents including parents of children who have received care for two conditions — asthma and chronic obstructive pulmonary disease — have been asked to assist in guiding the island’s healthcare ...